Paraneoplastic Mucous Membrane Pemphigoid with Ocular and Laryngeal Involvement Silvia Lambiel,1 Pavel Dulguerov,2 Emmanuel Laffitte,3 Igor Leuchter4

Total Page:16

File Type:pdf, Size:1020Kb

Paraneoplastic Mucous Membrane Pemphigoid with Ocular and Laryngeal Involvement Silvia Lambiel,1 Pavel Dulguerov,2 Emmanuel Laffitte,3 Igor Leuchter4 BMJ Case Reports: first published as 10.1136/bcr-2017-220887 on 11 August 2017. Downloaded from Rare disease CASE REPORT Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement Silvia Lambiel,1 Pavel Dulguerov,2 Emmanuel Laffitte,3 Igor Leuchter4 1Département des SUMMARY as the challenging multidisciplinary management of Neurosciences Cliniques, A 73-year-old woman was treated 8 years previously paraneoplastic MMP. Hôpitaux Universitaires de for synchronous breast and uterine neoplasms. She Genève, Geneva, Switzerland 2 presented with a severe sore throat, odynophagia, CASE PRESENTATION Département des Neurosciences Cliniques, dysphonia, dyspnoea, ocular irritation and weight A 73-year-old Caucasian woman presented to the Hôpitaux Universitaires de loss over the last 3 months. Physical examination ear–nose–throat clinic with a diffuse oral burning Genève, Geneva, Switzerland revealed ulcerations in the oral cavity, posterior sensation and disabling pharyngodynia over the last 3Département des Spécialités pharyngeal wall and supraglottic larynx, nasal crusting, 3 months. She reported weight loss with asthenia, de Médecine, Hôpitaux bilateral conjunctivitis and three cutaneous blisters. cough when lying down, hoarseness and dyspnoea. Universitaires de Genève, A diagnosis of anti-laminin 5 mucous membrane Previous treatments included topical and systemic Geneva, Switzerland pemphigoid was retained, based on skin biopsy, direct antifungal agents because of Candida-positive 4Département des immunofluorescence and immunoprecipitation. A oral swabs, antibiotics and antiviral therapy. Two Neurosciences Cliniques, positron emission tomography (PET)-CT detected multiple Hôpitaux Universitaires de previous oral biopsies revealed fibrin deposits with Genève, Geneva, Switzerland adenopathies. Cytology revealed adenocarcinoma with leucocytes without malignant cells. She had been an immunocytology compatible with a breast origin and treated during the previous month for bilateral Correspondence to this was considered as a late metastatic recurrence of ocular irritation and nail inflammation of the right Silvia Lambiel, her previous breast cancer. A treatment of prednisone, index finger by topical antibiotic drops and partial silvialambiel@ gmail. com dapsone and hormonotherapy was introduced, but nail avulsion, respectively. intravenous immunoglobulin and rituximab were added Her past medical history was marked by two Accepted 4 August 2017 due to new mucosal lesions. Despite treatment, a simultaneous cancers: a breast carcinoma and an posterior laryngeal scar and bilateral symblepharon were endometrial adenocarcinoma. These had been developed. After 3 years, the patient is still alive and treated successfully 8 years previously by right reports a satisfactory quality of life. mastectomy, axillary dissection, adjuvant radio- therapy and hormonotherapy, and by adnexectomy http://casereports.bmj.com/ and hysterectomy, respectively. At the last gynae- BACKGROUND cological examination, there was no sign of recur- Mucous membrane pemphigoid (MMP), also rence. referred to as cicatricial pemphigoid, is a rare Clinical examination revealed bilateral conjunc- bullous disease affecting predominantly mucosal tival inflammation and three blister-type skin sites and occasionally the skin in about 25% of lesions on the arms and legs. Inspection of the oral cases.1 Unfortunately, most specialists in oral cavity showed mucosal ulcerations of the ventral pathology or otolaryngology are unfamiliar with tongue (figure 1), cheeks, soft palate (figure 2), this disease. The most commonly affected sites uvula and posterior oropharyngeal wall. A flex- include the oral cavity and eye, followed by the ible transnasal endoscopy revealed crusts on the on 28 September 2021 by guest. Protected copyright. nasal, anogenital and pharyngeal mucosa and, right middle turbinate and nasopharynx, as well as less frequently, the oesophagus and larynx.2 The diffuse whitish pseudomembrane-covered erosions protean phenotypical manifestations are related to of almost all the supraglottic area and posterior the sites involved, age of the lesions and severity of hypopharyngeal wall (figure 3). the disease. The natural course of untreated lesions is irreversible scarring, which can result in airway INVESTIGATIONS obstruction and blindness in the case of laryngeal Full blood tests were unremarkable. A perilesional and ocular involvement, respectively. Some studies skin biopsy of a bullous lesion on the left leg revealed have evoked the possible association between MMP subepithelial cleavage with a rare eosinophilic infil- and malignant neoplasms when autoantibodies to trate on routine histopathological haematoxylin laminin 5 are present,3–7 arguing that anti-laminin 5 and eosin staining (figure 4). Direct immunofluo- MMP could be a paraneoplastic manifestation, but rescence analysis revealed a linear deposit of IgG T Lambiel S,o cite: this notion remains controversial.8 and C3 at the dermo-epidermal junction (figures 5 Dulguerov P, Laffitte E, et al. Herein, we report a rare case of MMP where and 6). Indirect immunofluorescence analysis was BMJ Case Rep Published negative. Immunoblotting studies demonstrated Online First: [please several mucosal sites were involved, leading to include Day Month Year]. cicatricial lesions despite adequate treatment. The circulating autoantibodies to bullous pemphigoid doi:10.1136/bcr-2017- association between anti-laminin 5 autoantibodies (BP)180 and laminin 5 (ELISA-BP 180 +: 26.99 U/ 220887 and metastatic breast carcinoma is discussed, as well mL; ELISA-BP 230: −). Lambiel S, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-220887 1 BMJ Case Reports: first published as 10.1136/bcr-2017-220887 on 11 August 2017. Downloaded from Rare disease Figure 1 Intra-oral view of a right sublingual erosion covered with Figure 3 Laryngoscopy showing diffuse whitish pseudomembranes fibrin (black arrow) and a left healing ulcer (yellow arrow). Tongue covering the epiglottis and both aryepiglottic folds and arytenoids. frenulum (red arrow). between these entities relies on clinical criteria. Pemphigus A diagnosis of MMP on clinical and immunohistological disease is distinguished from MMP by clinically flaccid blisters criteria was made, including diffuse oral, ocular, nasal, cuta- and suprabasal acantholysis on histopathology. neous, pharyngeal and laryngeal involvement. Given the past In oral lichen planus, fibrinogen deposition is encountered in oncological history and the presence of anti-laminin 5 antibodies, the basement membrane zone, but neither IgG, IgA nor C3 is a PET-CT scan was performed and revealed a left supraclavicular present. and multiple retroperitoneal adenopathies. Ultrasound-guided and CT-guided fine-needle biopsies were compatible with meta- TREATMENT static adenocarcinoma of breast origin, were hormone depen- The patient was treated initially with intravenous dexametha- dent and were considered as a late metastatic recurrence of the sone 4 mg three times daily for 3 days, followed by oral pred- previous breast tumour, without locoregional relapse. nisone (30 mg/day) in conjunction with dapsone at increasing doses: 50 mg/day during the first week; 75 mg/day during the DIFFERENTIAL DIAGNOSIS second week; and 100 mg/day thereafter. Hormonal therapy Diagnosis of MMP is based on clinical features, routine histo- with letrozole 2.5 mg/day was also started. A nasogastric feeding pathological study (subepithelial split), immunohistological tube was initially necessary, but a rapid clinical improvement http://casereports.bmj.com/ examination (linear deposition of IgG, IgA or C3 along the base- in the pharynx and larynx allowed the patient to resume oral ment membrane zone on direct immunofluorescence) and serum intake. antibody analysis (indirect immunofluorescence; detection of autoantigens including BP antigen 1 (BPAg1 or BP230), BP OUTCOME AND FOLLOW-UP antigen 2 (BPAg2 or BP180), integrin subunits alpha-6/beta-4, The active oral lesions completely disappeared initially. laminin 5, laminin 6 and type VII collagen by immunoblotting However, after 2 months, a transnasal endoscopy revealed an and immunoprecipitation techniques).1 Although BP has similar direct immunofluorescence features, the skin is predominantly affected and the differential diagnosis on 28 September 2021 by guest. Protected copyright. F igure 2 View of the oropharynx showing an ulcer with fibrin deposit Figure 4 Haematoxylin and eosin stain: subepithelial split on a of the right soft palate (yellow arrow); uvula (black arrow). perilesional skin biopsy. 2 Lambiel S, et al. BMJ Case Rep 2017. doi:10.1136/bcr-2017-220887 BMJ Case Reports: first published as 10.1136/bcr-2017-220887 on 11 August 2017. Downloaded from Rare disease Figure 5 Direct immunofluorescence of a bullous skin lesion. Linear Figure 7 Laryngoscopy showing interarytenoid synechia (arrow). IgG deposition at the basement membrane. DISCUSSION interarytenoid synechia with a somewhat decreased laryngeal MMP is a rare autoimmune subepithelial bullous disease char- patency (figure 7), while the ophthalmic examination showed acterised by the linear deposition of IgG, IgA or C3 along the bilateral moderate symblepharon without active inflammation. epithelial basement membrane zone and affecting predominantly Due to a mild haemolysis and general ill feeling when taking mucous membranes.2 The true incidence remains unknown, but dapsone, intravenous immunoglobulin was introduced (every it has been estimated
Recommended publications
  • Exacerbation of Galli-Galli Disease Following Dialysis Treatment: a Case Report and Review of Aggravating Factors
    Open Access Case Report DOI: 10.7759/cureus.15401 Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors Tejas P. Joshi 1 , Sally Shaver 2 , Jaime Tschen 3 1. Dermatology, Baylor College of Medicine, Houston, USA 2. Dermatology, Conroe Dermatology Associates, Conroe, USA 3. Dermatology, St. Joseph Dermatopathology, Houston, USA Corresponding author: Tejas P. Joshi, [email protected] Abstract Galli-Galli disease (GGD) is a rare genodermatosis that is an acantholytic variant of Dowling-Degos disease that presents as lentigo-like macules/papules with progressive reticulated hyperpigmentation. Heat, sweat, ultraviolet light exposure, and topical retinoids have been reported to exacerbate the lesions associated with GGD. Here, we present a 77-year-old woman with end-stage renal disease and GGD who reported a worsening of lesions during the summer months and following hemodialysis treatment. Despite the severity of her lesions following dialysis, she refused treatment with isotretinoin out of concern for its side effect profile. In this case report, we discuss some available treatment options for GGD and review the exacerbating factors for GGD currently reported in the literature. Categories: Dermatology Keywords: galli-galli disease, dowling-degos disease, genodermatosis, dialysis, contact dermatitis, end-stage renal disease Introduction Galli-Galli disease (GGD) is a rare, autosomal dominant genodermatosis that is an acantholytic variant of Dowling-Degos disease (DDD). DDD encompasses a spectrum of skin conditions that present with progressive reticulated hyperpigmentation; while GGD was initially postulated to be a distinct entity from DDD, more recent evidence has led to the consensus that GGD is a variant of DDD [1].
    [Show full text]
  • Histopathology of Porphyria Cutanea Tarda 133
    HISTOPATHOLOGY OF PORPHYRIA CTJTANEA TARDA*t MATJRIMAURI FELDAKER, FELDAKER, M.D., MD., HAMILTON MONTGOMERY, M.D. AND LOUIS A. BRUNSTING, M.D.MD. We wish to report the results of the histopathologic examination of the skin in 11 patients \vithwith porphyria cutanea tardatarda whowho werewere examinedexamined betweenbetween 19461946 and 1954. The microscopic findings in two patients (numbers I nndand 2) havehnve beenbeen reported previously by Brunsting and Mason (1). A preliminary report of the histopathologic findings in the first 10 patients has been given by Brunsting (2). MATERIAL Eleven patients, 10 men and one woman, with porphyria cutanea tarda were included in this study. One or more cutaneous biopsy specimens from each patient were fixed with 10 per cent formalin and stained with hematoxylin and eosin,eosiu, various elastic-tissue stains such as elastin H (Grubler), and an modified aldehyde-fuchsin stain (3)t whichwhich wewe preferprefer toto thethe elastinelastin HH oror WeigertWeigert stain, stain van Gieson stain forfor collagen,collagen, periodicperiodic acid acid Schiff Schiff stain stain (P.A.S., (PAS., that is, Hotch- kiss-McManus stain) for polysaccharides with and without pretreatment with diastase, mucin stains such as mucin D (4) counterstained with 2 per cent indigo carmine, Mallory's potassium ferrocyanide stain for the demonstration of hemo- siderin, and silver nitrate stain counterstained with\vith hematoxylin to demonstrate melanin. Stains for amyloid, Maresch-Bielschowsky stain for reticulum fibers (Gitterfasern) arid the Giemsa stain to demonstrate mast cells were done on all specimens. Biopsy was performed on the dorsum of the hand or finger iiiin about 50 per cent of the patients and, with one exception, all specimens were removed from thethe usuallyusually exposed areas of the body.
    [Show full text]
  • Download Article
    SKINTEST Skin Test Christina P. Linton 1. Which fungal strain is the most common cause 6. Which of the following conditions is characterized of tinea capitis in the United Kingdom and by intraepidermal blistering? North America? a. Bullous pemphigoid a. Trichophyton tonsurans b. Porphyria cutanea tarda b. Microsporum audouinii c. Herpesvirus infection c. Trichophyton rubrum d. Dermatitis herpetiformis d. Microsporum canis 7. What is the mechanism of action of injectable local 2. What percentage of cells in the epidermis are anesthetics? keratinocytes? a. Blockage of potassium channels a. 50% b. Inhibition of cyclooxygenase b. 65% c. Blockage of sodium channels c. 80% d. Inhibition of prostaglandins d. 95% 8. Which of the following statements most accurately 3. Which of the following conditions is inherited in describes pemphigus vulgaris? X-linked fashion? a. Onset is most common in the third and fourth a. Tuberous sclerosis decades of life. b. Incontinenta pigmenti b. Initial lesions generally occur on the trunk. c. Ataxia telangiectasia c. Auspitz sign is usually positive. d. Neurofibromatosis d. Untreated disease is commonly fatal. 4. What does the Greek root of the term ‘‘ichthyosis’’ 9. What does the term ‘‘acantholysis’’ refer to on a mean? dermatopathology report? a. Fish a. Loss of intercellular connections b. Crocodile b. Reduced thickness of the granular layer c. Elephant c. Abnormal retention of keratinocyte nuclei d. Lizard d. Intercellular edema 5. Lichen striatus most commonly occurs in which 10. Approximately what percentage of untreated anatomic location? syphilis cases progressed to tertiary syphilis? a. Face a. 15% b. Chest b. 33% c. Abdomen c.
    [Show full text]
  • SKIN VERSUS PEMPHIGUS FOLIACEUS and the AUTOIMMUNE GANG Lara Luke, BS, RVT, Dermatology, Purdue Veterinary Teaching Hospital
    VETERINARY NURSING EDUCATION SKIN VERSUS PEMPHIGUS FOLIACEUS AND THE AUTOIMMUNE GANG Lara Luke, BS, RVT, Dermatology, Purdue Veterinary Teaching Hospital This program was reviewed and approved by the AAVSB Learning Objective: After reading this article, the participant will be able to dis- RACE program for 1 hour of continuing education in jurisdictions which recognize AAVSB RACE approval. cuss and compare autoimmune diseases that have dermatological afects, includ- Please contact the AAVSB RACE program if you have any ing Pemphigus Foliaceus (PF), Pemphigus Erythematosus (PE), Discoid Lupus comments/concerns regarding this program’s validity or relevancy to the veterinary profession. Erythematosus (DLE), Systemic Lupus Erythematosus (SLE). In addition, the reader will become familiar with diagnostic and treatment techniques. FUNCTION OF THE SKIN Te skin is the largest organ of the body. Along with sensory function, it provides a barrier between the inside and outside world. Te epidermis is composed of the following fve layers: stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and stratum corneum. Te stratum lucidum is found only on the nasal planum and footpads. When the cells of the epidermis are disrupted by systemic disease, the barrier is also disrupted. Clinical signs of skin disease will bring the patient into the veterinarian’s ofce for diagnosis. 32 THE NAVTA JOURNAL | NAVTA.NET VETERINARY NURSING EDUCATION THE PEMPHIGUS COMPLEX article.3 Histologically it shares characteris- Pemphigus Foliaceus tics of both PF and DLE.1 This classifcation PF is an immune mediated pustular disor- is still considered controversial and PE may der included in a group of diseases known just be a localized variant of PF.1 as the pemphigus complex.
    [Show full text]
  • Think Clinical Immunodermatology Laboratory
    Clinical ImmunodermatologyThink ImmunodermatologyLaboratory Testing! Kristin M. Leiferman, M.D. Professor of Dermatology Co-Director Immunodermatology Laboratory University of Utah History Late 1800s Paul Ehrlich put forth the concept of autoimmunity calling it “horror autotoxicus” History Early 1940s Albert Coons was the first to conceptualize and develop immunofluorescent techniques for labeling antibodies History 1945 Robin Coombs (and colleagues) described the Coombs antiglobulin reaction test, used to determine if antibodies or complement factors have bound to red blood cell surface antigens in vivo causing hemolytic anemia •Waaler-Rose rheumatoid factor •Hargraves’ LE cell •Witebsky-Rose induction of thyroiditis with autologous thyroid gland History Mid 1960s Ernest Beutner and Robert Jordon demonstrated IgG cell surface antibodies in pemphigus, autoantibodies in circulation and bound to the dermal-epidermal junction in bullous pemphigoid Immunobullous Diseases Immunobullous Diseases • Desmogleins / Desmosomes – Pemphigus • BP Ags in hemidesmosomes / lamina lucida – Pemphigoid – Linear IgA bullous dermatosis • Type VII collagen / anchoring fibrils – Epidermolysis bullosa acquisita Immunodermatology Tests are Diagnostic Aids in Many Diseases • Dermatitis herpetiformis & • Mixed / undefined celiac disease connective tissue disease • Drug reactions • Pemphigoid (all types) • Eosinophil-associated disease • Pemphigus (all types, including paraneoplastic) • Epidermolysis bullosa acquisita • Porphyria & pseudoporphyria • Lichen planus
    [Show full text]
  • How to Deal with Skin Biopsy in an Infant with Blisters?
    Review How to Deal with Skin Biopsy in an Infant with Blisters? Stéphanie Leclerc-Mercier Reference Center for Genodermatoses (MAGEC Center), Department of Pathology, Necker-Enfants Malades Hospital, Paris Centre University, 75015 Paris, France; [email protected] Abstract: The onset of blisters in a neonate or an infant is often a source of great concern for both parents and physicians. A blistering rash can reveal a wide range of diseases with various backgrounds (infectious, genetic, autoimmune, drug-related, traumatic, etc.), so the challenge for the dermatologist and the pediatrician is to quickly determine the etiology, between benign causes and life-threatening disorders, for a better management of the patient. Clinical presentation can provide orientation for the diagnosis, but skin biopsy is often necessary in determining the cause of blister formations. In this article, we will provide information on the skin biopsy technique and discuss the clinical orientation in the case of a neonate or infant with a blistering eruption, with a focus on the histology for each etiology. Keywords: blistering eruption; infant; skin biopsy; genodermatosis; SSSS; hereditary epidermolysis bul- losa; keratinopathic ichthyosis; incontinentia pigmenti; mastocytosis; auto-immune blistering diseases 1. Introduction The onset of blisters in a neonate or an infant (<2 years old) is a source of great concern for both parents and physicians. Therefore, a precise diagnosis, between benign causes and Citation: Leclerc-Mercier, S. How to life-threatening disorders, is quickly needed for the best management of the baby. Deal with Skin Biopsy in an Infant Several diseases with various backgrounds (infectious, genetic, autoimmune, drug- with Blisters? Dermatopathology 2021, related, traumatic, etc.) can lead to a blistering eruption.
    [Show full text]
  • UC Davis Dermatology Online Journal
    UC Davis Dermatology Online Journal Title Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient Permalink https://escholarship.org/uc/item/24v5t78z Journal Dermatology Online Journal, 25(4) Authors Kanitakis, Jean Gouillon, Laurie Jullien, Denis et al. Publication Date 2019 DOI 10.5070/D3254043575 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 25 Number 4| April 2019| Dermatology Online Journal || Case Presentation 25(4):6 Multiple acantholytic dyskeratotic acanthomas in a liver- transplant recipient Jean Kanitakis1,2, Laurie Gouillon1, Denis Jullien1, Emilie Ducroux1 Affiliations: 1Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France, 2Department of Pathology, Centre Hospitalier Lyon Sud, Pierre Bénite, France Corresponding Author: Jean Kanitakis, Department of Dermatology, Edouard Herriot Hospital Group (Pavillion R), 69437 Lyon cedex 03, France, Tel: 33-472110301, Email: [email protected] (0.5mg/d) and prednisolone (5mg/d). He had Abstract recently developed end-stage renal disease and was Acantholytic dyskeratotic acanthoma is a rare variant undergoing hemodialysis. His post-transplant of epidermal acanthoma characterized pathologically medical history was significant for two melanomas by the presence of acantholysis and dyskeratosis. (one in situ on the abdomen diagnosed at the age of Few cases have been reported until now, one of them 61 years and a superficial spreading melanoma in a heart-transplant patient. We present here a new 2.4mm Breslow thickness of the dorsum of the foot case of this rare lesion that developed in a liver- diagnosed ten years later), a squamous cell transplant patient and review the salient features of this uncommon condition.
    [Show full text]
  • Immunofluorescence in Dermatology
    CONTINUING MEDICAL EDUCATION Immunofluorescence in dermatology Diya F. Mutasim, MD, and Brian B. Adams, MD Cincinnati, Ohio The accurate diagnosis of bullous and other immune diseases of the skin requires evaluation of clinical, histologic, and immunofluorescence findings. Immunofluorescence testing is invaluable in confirming a diagnosis that is suspected by clinical or histologic examination. This is especially true in subepidermal bullous diseases that often have overlap in the clinical and histologic findings. Direct immunofluorescence is performed on perilesional skin for patients with bullous diseases and lesional skin for patients with connective tissue diseases and vasculitis. (J Am Acad Dermatol 2001;45:803-22.) Learning objective: At the completion of this learning activity, participants should be familiar with the ideal method of obtaining immunofluorescence testing for the diagnosis of immune skin diseases and be aware of the value and limitations of immunofluorescence studies. mmunofluorescence has been used for 4 decades, both to investigate pathophysiology of Abbreviations used: skin disorders and to help physicians in the diag- I BMZ: basement membrane zone nosis of various cutaneous disorders, especially bul- BP: bullous pemphigoid lous diseases and connective tissue diseases. This CP: cicatricial pemphigoid article addresses the present status of immunofluo- DEJ: dermoepidermal junction rescence in dermatology. DH: dermatitis herpetiformis DIF: direct immunofluorescence DIAGNOSIS AND PATHOPHYSIOLOGY OF DLE: discoid lupus erythematosus BULLOUS DISEASES EBA: epidermolysis bullosa acquisita Great progress has been made during the past 5 HG: herpes gestationis decades in our understanding of the biology of the HSP: Henoch-Schönlein purpura ICS: intercellular space skin as it relates to bullous diseases. This has led to IIF: indirect immunofluorescence more accurate classification and diagnosis.
    [Show full text]
  • Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists
    OBSERVATION Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists Vu Thuong Nguyen, PhD; Juan Arredondo, PhD; Alexander I. Chernyavsky, PhD; Mark R. Pittelkow, MD; Yasuo Kitajima, MD, PhD; Sergei A. Grando, MD, PhD, DSc Background: Pemphigus vulgaris (PV) is an autoim- phorylation level of E-cadherin and plakoglobin was in- mune, IgG autoantibody–mediated disease of skin and mu- creased by PV IgG, whereas this effect of PV IgG was at- cosa leading to progressive blistering and nonhealing ero- tenuated in the presence of 0.5mM carbachol. sions. Patients develop autoantibodies to adhesion Pyridostigmine bromide, an acetylcholinesterase inhibi- molecules mediating intercellular adhesion and to kerat- tor, produced effects similar to those of carbachol, which inocyte cholinergic receptors regulating cell adhesion. helps explain its clinical efficacy in a patient with active PV that was resistant to treatment with systemic gluco- Observations: To determine whether a cholinergic ago- corticosteroids. Treatment with pyridostigmine bro- nist can abolish PV IgG–induced acantholysis, litter mates mide (360 mg/d) in a patient with PV allowed to keep of neonatal athymic nude mice were injected with PV IgG his disease under control at a lower dose of prednisone together with carbachol (0.04 µg/g body weight). None than that used before starting pyridostigmine bromide of these mice developed skin lesions. Through in vitro treatment. experiments, we measured the expression of adhesion molecules in monolayers of normal human keratino- Conclusion: Elucidation of the cholinergic control of ke- cytes incubated overnight in the presence of 0.25mM car- ratinocyte adhesion merits further consideration be- bachol using semiquantitative Western blot and immu- cause of a potential for the development of novel anti- nofluorescence.
    [Show full text]
  • Oral Mucous Membrane Pemphigoid Without Skin Involvement Treated
    Central Journal of Dermatology and Clinical Research Case Report *Corresponding author Manas Bajpai, Associate Professor, Departmentt of Oral and Maxillofacial Pathology, NIMS Dental Oral Mucous Membrane College, Jaipur, India, Email: Pemphigoid without Skin Submitted: 08 June 2017 Accepted: 22 June 2017 Published: 23 June 2017 Involvement Treated by Intra- Copyright © 2017 Bajpai et al. Venous Immunoglobulins: A Case OPEN ACCESS Keywords Report with the Correlation of • Mucous membrane pemphigoid • Oral mucosa • Immunoflurescence Clinical, Histopathological and • Intra – venous immunoglobulins Direct Immunoflurescence Findings and a Literature Review of the Treatment Modalities Manas Bajpai*and Nilesh Pardhe Department of Oral and Maxillofacial Pathology, NIMS Dental College, India Abstract Mucous membrane pemphigoid (MMP) is an autoimmune blistering disorder of mucosa, characterized by subepithellial bullae. The involvement of skin is only seen in one quarter of the patients with MMP. We report a case of 37 years old male presented with painful erosions involving gingiva, tongue and palatal mucosa without any skin involvement. Hisopathological features and direct immunofluroscene l to the final diagnosis of MMP. INTRODUCTION since 6 months for which no response was found. The lesions of palate, tongue and lip were extremely painful due to which he group of autoimmune heterogeneous disorder characterized Mucous membrane pemphigoid (MMP) can be defined as a contributory to the presenting symptom. Intra oral examination by subepithelial blistering disease primarily affecting mucous revealedexperienced erosions difficulty of labial in eating. mucosa His (Figure family 1) history and palate was (Figure non – membrane with or without involvement of skin [1,2]. Various 2). Localized desquamative marginal gingivitis was noted with relation to teeth #12, #21, #22 and #33 (Figure 3).
    [Show full text]
  • Painful Mouth Ulcers
    DERMATOPATHOLOGY DIAGNOSIS Painful Mouth Ulcers Gabriela Rosa, MD; Melissa Piliang, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis article in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumu- lating multiple credits. A 41-year-old woman presented with painful ulcers on the oralcopy mucosa of 2 months’ duration that were unresponsive to treatment with acyclovir. She had been diagnosed with a pelvic tumor a few weeks prior to the development of the mouth ulcers.not Direct immunofluorescence of the perile- sional mucosa showed positive IgG and comple- ment C3 with an intercellular distribution. A biopsy Doof an oral lesion was performed. H&E, original magnification ×200. THE BEST DIAGNOSIS IS: a. graft-versus-host disease b. lichen planus c. paraneoplastic pemphigus d. Stevens-Johnson syndrome CUTIS e. subacute cutaneous lupus erythematosus PLEASE TURN TO PAGE 341 FOR THE DIAGNOSIS From the Departments of Dermatology and Pathology, Cleveland Clinic Foundation, Ohio. The authors report no conflict of interest. Correspondence: Gabriela Rosa, MD, 700 S Park St 1 SW, Madison, WI 53715 ([email protected]). WWW.CUTIS.COM VOL. 101 NO. 5 I MAY 2018 327 Copyright Cutis 2018. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher.
    [Show full text]
  • Incidental Cutaneous Reaction Patterns: Epidermolytic
    Hindawi Publishing Corporation Journal of Skin Cancer Volume 2011, Article ID 645743, 5 pages doi:10.1155/2011/645743 Research Article Incidental Cutaneous Reaction Patterns: Epidermolytic Hyperkeratosis, Acantholytic Dyskeratosis, and Hailey-Hailey-Like Acantholysis: A Potential Marker of Premalignant Skin Change Erich M. Gaertner SaraPath Diagnostics, 2001 Webber Street, Sarasota, FL 34239, USA Correspondence should be addressed to Erich M. Gaertner, [email protected] Received 8 December 2010; Accepted 28 January 2011 Academic Editor: M. Lebwohl Copyright © 2011 Erich M. Gaertner. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Focal acantholytic dyskeratosis (FAD), epidermolytic hyperkeratosis (EHK), and Hailey-Hailey-like acantholysis (HH) represent unique histology reaction patterns, which can be associated with defined phenotypic and genotypic alterations. Incidental microscopic foci demonstrating these patterns have been identified in skin and mucosal specimens in association with a gamut of disease processes. These changes, when secondary, are of unclear etiology and significance. The following study further analyzes the incidence and association of these histologic patterns in a routine pathology/dermatopathology practice. 1. Introduction focal acantholytic dyskeratosis (FAD). Subsequently, 500 consecutive skin specimens were reviewed by the author A variety of incidental microscopic cutaneous changes have (8/08-9/08) at a different institution to evaluate for incidental been described in skin and mucosal specimens. Whether foci of epidermolytic hyperkeratosis (EHK). An incidental these represent spurious changes of no consequence, or true focus was defined as a minor histologic finding occurring manifestations of underlying cellular alterations, remains within a biopsy or excision specimen demonstrating a unclear.
    [Show full text]